The Ganesha Lab

What The Ganesha Lab does

The Ganesha Lab is a privately held biotech scale-up lab headquartered in Santiago, Chile, founded in 2017, that operates an accelerator and internationalization platform for early-stage science and technology-based startups across Latin America. The company runs the BIGinBIO program, a 3-month intensive acceleration cycle that has graduated nine cohorts of portfolio companies and now receives over 80 applications per cycle, supplemented by specialized tracks including the BIGinBIO US Market Program, the Go Europe Connect program for European market entry, the International Market Validation (IMV) Program, and a two-week US Soft-Landing Program conducted jointly with Cambridge Innovation Center (CIC) Miami. The Ganesha Lab does not develop proprietary technology itself; instead, it operates a "platform-plus-programs" architecture centered on mentoring, investor readiness, and cross-border market access for portfolio companies spanning life sciences, biotech, agrifood, medical devices, and digital health.

The company's go-to-market is built on annual open calls selecting small cohorts of startups from a substantially larger applicant pool, with applications growing over 100% year-over-year for BIGinBIO 2023. Revenue derives primarily from professional services for acceleration programming, with value capture also through portfolio growth, strategic investor partnerships, and corporate sponsorship from organizations including Johnson & Johnson, Thermo Fisher Scientific, and Life Science Nation. Pricing is not publicly disclosed and the program is selectively gated through an application process. With a core team of fewer than 10 employees plus an extended mentor network of approximately 20 senior advisors drawn from Johnson & Johnson, UC Davis Venture Catalyst, and Life Science Nation, the company operates as a lean platform whose reach is materially amplified by its partnerships — most notably the 2025 Life Science Nation alliance providing access to 4,000+ global investor and licensing partner profiles and the São Paulo biotech accelerator hub set to go live by late 2025 or early 2026.

Portfolio achievements include $80M+ raised collectively by featured startups, a cumulative portfolio valuation of $118M with a projected $165M for end-2022, and individual recognitions including a FoodTech 500 placement, Grow-NY competition victory, ICIS Best Process Innovation Award, and a US patent for portfolio company metaBIX Biotech's CAPTUS device. The Ganesha Lab serves countries across Latin America (Chile, Brazil, Uruguay, Argentina, Mexico, Colombia, Costa Rica, Peru), the United States, and Europe, and has begun establishing a regional headquarters footprint in São Paulo.

Name

The Ganesha Lab

Legal name

The Ganesha Lab

Website

https://theganeshalab.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

The Ganesha Lab is a Santiago, Chile-based biotech scale-up lab operating the BIGinBIO accelerator program, providing mentoring, investor readiness, and cross-border market access to early-stage Latin American science-based startups in life sciences, biotech, agrifood, and medical devices.

Ownership category

akta.pro rank

Product category

Biotech Acceleration Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Corporate Accelerators & Startup Programs (FSANAHAD)

Keywords

• Biotech acceleration services
• Startup scale-up programs
• Life sciences mentoring
• Investor readiness support
• International market access

Headquarters

HQ city

Santiago

HQ country

Chile

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Scale-up Program Services: The Ganesha Lab provides acceleration services to selected biotech startups through its BIGinBIO program. The organization generates value through portfolio company growth, investment returns, and strategic partnerships with investors and corporations seeking access to Latin American biotech innovations.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

The Ganesha Lab is a global life sciences scale-up lab that operates the BIGinBIO Program, a 3-month intensive acceleration program providing strategic mentoring, investor readiness training, and global market access for early-stage Latin American science-based startups in biotech, life sciences, and agrifood sectors. The program is supplemented by specialized tracks including the BIGinBIO US Market Program, Go Europe Connect Program for European expansion, a 2-month International Market Validation Program, and a US Soft-Landing Program conducted jointly with Cambridge Innovation Center Miami. Top-performing startups receive continuous support for a minimum of 3 years post-program.

Product overview

The Ganesha Lab is a global life sciences scale-up lab based in Latin America that operates as a platform-plus-programs architecture. The core offering is the BIGinBIO Program, a signature scale-up and acceleration program for science-based startups that provides strategic mentoring, investor readiness, and global market access. This core program is supplemented by specialized tracks including the BIGinBIO US Market Program for US market entry, the Go Europe Connect Program for European expansion, the International Market Validation (IMV) Program for intensive US-based market scaling, and a US Soft-Landing Program conducted with Cambridge Innovation Center Miami. Together, these programs transform high-potential science-based startups into successful, scalable international businesses through structured readiness programs, industry connections, and access to early-stage capital.

Differentiator

Problem solved

Functional benefit

Products and services

• BIGinBIO Program The signature scale-up and international acceleration program for science and technology-based startups in Latin America, providing mentoring, workshops, and access to international markets through soft-landing programs in the US and Europe. Designed for early-stage biotech, life sciences, and agrifood startups.
• BIGinBIO US Market Program Specialized track within the BIGinBIO program focused on supporting Latin American biotech startups in early-growth stage to enter and scale in the US market, leveraging the Life Science Nation partnership for investor and licensing partner access.
• Go Europe Connect 2025 Program Program designed to support Latin American science and technology-based projects and startups in expanding into the European market through structured internationalization support.
• International Market Validation (IMV) Program Two-month intensive program where entrepreneurs scale their business through face-to-face work with investors, mentors, and potential clients in the United States. Reserved for top performers of the BIGinBIO program.
• US Soft-Landing Program

Quantifiable outcome

• Portfolio valuation reached USD 118 million with projection of USD 165 million for end of 2022
• +1 more outcomes

Named customers8 records

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eleven partnerships are on record, tiered flagship, core and minor.

• Life Science Nation (LSN)flagshipStrategic or Co-development Partner · 30 September 2025Strategic partnership to establish a dedicated biotech accelerator hub in São Paulo, Brazil by end of 2025. LSN contributes global reach with 4,000+ investor and licensing partner profiles, AI-driven readiness tools, and $5B raised across 400+ companies. The partnership connects Latin America's scientific talent with the global healthcare innovation ecosystem.
• Venture Catalyst (UC Davis)coreStrategic or Co-development PartnerPartnership with Venture Catalyst enabling the Worldwide Accelerated Research Partnerships (WARP) program at UC Davis, helping startups access global industry and transform their mindset for international markets.
• Johnson & JohnsoncoreStrategic or Co-development PartnerCo-creating the future of human health with global startup ecosystem. Johnson & Johnson recognizes Latin American scientists and entrepreneurs need strategic partners like The Ganesha Lab to accelerate innovation and scale globally.
• Cambridge Innovation Center (CIC) MiamicoreImplementation/ SI/ Consulting PartnerJoint US virtual soft-landing program conducting 2-week immersion for startups to understand the US market from up close, part of the BIGinBIO acceleration program.
• ChileGlobal AngelscoreChannel Partner/ Reseller/ DistributorPartnership with ChileGlobal Angels, a prominent network of angel investors in Chile, to host BIOINVEST: the premier Latam Biotech Investment Forum spotlighting innovative biotech startups.
• Merken BiotechcoreStrategic or Co-development PartnerStrategic partnership to propel biotechnology in Latin America, reshaping the biotech landscape through collaborative efforts.
• Fundación Ciencia y Vida (FCV)coreStrategic or Co-development PartnerAgreement between The Ganesha Lab and FCV to foster collaboration in scientific and technological fields, including HealthTech advancement.
• Thermo Fisher ScientificminorStrategic or Co-development PartnerCross Intelligence program led by Thermo Fisher Scientific welcomes The Ganesha Lab. InnovaCell supports Thermo Fisher Scientific Latin America in strategic innovation and digital transformation initiatives.
• KhemBIO (Uruguay)coreChannel Partner/ Reseller/ DistributorCo-organization of BornGlobal events with Uruguay's local incubator KhemBIO to promote biotechnology from Uruguay to the world, gathering nearly 140 major ecosystem stakeholders.
• Fundación ChileminorStrategic or Co-development PartnerCollaboration with Fundación Chile to host the successful launch of the Deep Tech Report in Latin America and the Caribbean.
• Hatch BlueminorChannel Partner/ Reseller/ DistributorAQUIT, portfolio startup replacing antibiotics in fish treatment, joined Hatch Blue's aquaculture program for international market access.

Scale indicators5 records

Recent moves9 records

Expansion highlights6 records

Regional players

• Imagine Labs: Mexico-based deep-tech and science-based startup accelerator. Comparable in focusing on science-driven founders in Latin America and providing international market access support, though at smaller scale.
• Start-Up Chile: Chilean government-backed equity-free startup accelerator based in Santiago. Direct regional peer operating the same local ecosystem and competing for the same Chilean founder pool, but with a broader sector mandate.
• NXTP Labs: LatAm-focused early-stage VC and accelerator program. Comparable as a regional startup platform for early-stage founders, but with broader sector exposure than TGL's life-sciences-only mandate.

Direct peers

• 500 Global (formerly 500 Startups): Global accelerator with deep Latin America presence (Mexico, Brazil, Colombia). Comparable in regional accelerator model, startup sourcing across emerging markets, and investor-readiness curriculum.
• IndieBio: US-based biotech-focused accelerator (SOSV) that runs intensive programs for science-based startups. IndieBio is the most direct global comparable in model, cohort length, and biotech/life sciences focus, though it operates at larger scale and is US-anchored.

Broad incumbents

• MassChallenge: Global non-profit accelerator with a strong healthcare/biotech vertical. Comparable in zero-equity model targeting science-driven startups and corporate partnership model (similar to TGL's J&J/UC Davis links).
• Techstars: Global accelerator network with multiple industry verticals including healthcare/biotech. Comparable in accelerator mechanics (cohort-based, mentor-driven, investor access), but at much larger scale and not regionally specialized.
• Y Combinator: Largest global startup accelerator. Comparable in cohort-based acceleration model and investor network effects, but is sector-agnostic and headquartered in Silicon Valley rather than LatAm-anchored.
• Wayra (Telefónica): Corporate venture accelerator of Telefónica operating across multiple LatAm countries. Comparable as a corporate-backed accelerator with regional hubs and corporate pilot access for portfolio companies, though it is generalist rather than biotech-focused.

Others

• Hatch Blue: Aquatech/aquaculture-focused accelerator and fund. Indirectly comparable because TGL portfolio startup AQUIT joined Hatch's aquaculture program, making Hatch a complementary channel partner rather than a direct competitor in biotech acceleration.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/TheGaneshaLab
• LinkedInlinkedin.com/company/theganeshalab
• Instagraminstagram.com/theganeshalab

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments34 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Ganesha Lab